Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dilantin hypersensitivity reaction

L A Conger, W J Grabski

    Cutis
    |April 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Dilantin hypersensitivity syndrome presents with fever, rash, and hepatitis. Early recognition and stopping Dilantin (phenytoin) are crucial to prevent severe outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patterns of male reproductive success in a highly promiscuous whale species: the endangered North Atlantic right whale.

    Molecular ecology·2007
    Same author

    Surgical pearl: scroll-shaped electrode for electrodesiccation of actinic cheilitis.

    Journal of the American Academy of Dermatology·2000
    Same author

    Comparison of electrodessication with CO2 laser for the treatment of actinic cheilitis.

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2000
    Same author

    Evaluation and management of nonmelanoma skin cancer. The military perspective.

    Dermatologic clinics·1999
    Same author

    Positive surgical excision margins of a basal cell carcinoma.

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·1998
    Same author

    Lower extremity purpura associated with new-onset autoimmune hepatitis: an unusual presentation.

    Cutis·1998
    Same journal

    Black Dots on the Scalp of a Child.

    Cutis·2026
    Same journal

    Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

    Cutis·2026
    Same journal

    Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

    Cutis·2026
    Same journal

    The Future of Psoriasis Care.

    Cutis·2026
    Same journal

    Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

    Cutis·2026
    Same journal

    Metastatic Primary Extramammary Paget Disease: A Case Series.

    Cutis·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Toxicology
    • Dermatology

    Background:

    • Dilantin hypersensitivity syndrome is a severe adverse drug reaction.
    • It is associated with the anticonvulsant medication phenytoin (Dilantin).
    • Understanding its clinical manifestations is vital for patient safety.

    Observation:

    • The syndrome presents with characteristic symptoms including fever, rash, lymphadenopathy, facial edema, and hepatitis.
    • Associated symptoms can include anemia, pharyngitis, diarrhea, and nephritis.
    • Skin eruptions range from classic follicular papules to severe forms like erythroderma or toxic epidermal necrolysis.

    Findings:

    • The syndrome is a hypersensitivity reaction to phenytoin.
    • Clinical presentation is variable, encompassing a wide spectrum of dermatologic and systemic symptoms.

    Related Experiment Videos

  • Prompt diagnosis and withdrawal of phenytoin are key management strategies.

    • Implications:

    • Early identification of Dilantin hypersensitivity syndrome is critical for preventing potentially fatal outcomes.
    • Healthcare providers must be aware of the diverse clinical presentations.
    • Discontinuation of phenytoin is the primary treatment, necessitating alternative seizure management.